关于张强医生集团

张强医生集团（Dr. Smile Medical Group）成立于2014年7月1日，总部位于上海，法人机构为上海张强医疗科技股份有限公司，为中国首家医生集团，创始人为我国著名血管外科专家张强医生。目前集团在上海、北京、深圳、成都、广州等城市拥有亚洲最大连锁下肢静脉曲张治疗中心。

张强医生集团是首个发起和参与负责全球专项临床技术—CHIVA国际认证的中国医生团队，同时属于国家级静脉病专业委员会的主委单位，并负责主办静脉病国家级医学继续教育项目。作为国际静脉病论坛（GVF）、思俊国际静脉病学院线上教育主办方，张强医生团队在国内最早引入和应用多项静脉曲张治疗技术，包括内镜（SEPS）、静脉腔内射频消融、CHIVA等。

张强医生集团成功将传统下肢静脉曲张可能长达数天的住院治疗，缩短成为一小时左右的CHIVA门诊治疗，目前下肢静脉曲张微创治疗已服务两万余例，2021年患者满意度超过98.2%。

Dr. Smile Medical Group, founded on July 1, 2014, is the first medical group in China, founded by Dr. Smile, a renowned vascular surgeon in China, with its headquarters in Shanghai, China.

 In 2013, Dr. Smile established the first vein center in China, focusing on the diagnosis and treatment of varicose veins, venous thrombosis, venous ulcers and other venous diseases of the lower limbs. Now we have vein center in Shanghai, Beijing, Shenzhen, Chengdu, Guangzhou etc., and we are the largest chain of lower limb varicose veins treatment centers in Asia. Dr. Smile Medical Group has a professional team of phlebology specialists and the cutting-edge CHIVA minimally invasive treatment technology for varicose veins, which has treated more than 20,000 cases of varicose veins at home and abroad, making it at the forefront of the world.

 Meanwhile, Dr. Smile Medical Group has also established an international academic platform and cooperated with medical specialists from the United States, France, Italy, Japan, etc., to carry out technological innovation in varicose veins treatment and relevant medical instruments development.

 Dr. Smile Medical Group is the first medical group in Chinese medical field responsible for the international certification of global specialized medical clinical techniques, and also belongs to the main unit of the national professional committee for venous diseases, and has the qualification of national medical continuing education project. Meanwhile, as the host of Global Venous Forum（GVF）, one of the three major academic platforms for venous diseases in the world. Dr. Smile Medical Group was earliest in China to introduce and implement several technologies for the treatment of varicose veins in the lower limbs, including SEPS, radiofrequency ablation, and CHIVA, etc.

 Through the study of venous hemodynamics and the application of CHIVA, Dr. Smile Medical Group successfully shortened the traditional inpatient treatment of varicose veins in the lower limbs, which may take several days, into an outpatient treatment that takes about an hour, minimizing the complications of traditional surgery and saving a lot of time and subsequent recovery process for patients. More than 98.2% patient satisfaction in 2021.

 Dr. Smile is the founder of the Chinese medical group. Known as an expert in vascular surgery and a leader in the field of venous disease, Dr. Smile has continued to explore and innovate in his specialized field and pursued excellence, and has served as the director of vascular surgery in three public Grade A tertiary hospitals. He always strives to achieve the ultimate in phlebology, and eventually went outside the institution and successfully founded the first medical group in China.

 In August 2014, Dr. Smile Medical Group proposed the physician-hospital partnership (PHP) model for the first time in China.

 In June 2015, completed the shareholding reform.

 In February 2016, completed the first round of Pre-A financing.

 In March 2016, launched and established the Chinese medical group.

In October 2016, established the shared model vein center.

 In December 2016, won the “Oscar” of China’s medical and health industry, the CHIP Award.

 In February 2017, DR. SMILE MEDICAL GROUP was registered in the U.S.

 In August 2017, Dr. Smile Surgical Clinic, a chain of medical institutions under Dr. Smile Medical Group, was landed. After that, Surgeon Club and Surgeon Venous Disease Academy were established, and a national professional committee for the venous diseases was initiated and set up.

 In December 2018, won the “Top 10 Medical Group Brands” at Shanghai Medical Fair.

 In April 2019, hosted the Global Venous Forum (GVF) and published the first Asian Consensus on the CHIVA Treatment of Varicose Veins.

 In May 2021, signed a long-term strategic cooperation memorandum with Inteleos, a global medical certification organization, and launched the global CHIVA certification project, which is a remarkable milestone.

 In the future, Dr. Smile Medical Group will collaborate with more excellent doctors from all over the world and become the international leader in the specialized treatment of venous diseases.